Live®

  • Highly breathable, entry-level one-day lens for patients seeking convenience*1
Product specs

Description

Live® is a one-day replacement silicone hydrogel contact lens for myopic and hyperopic patients.

Features and Benefits

  • High oxygen transmissibility for breathability*1
  • AquaGen® Technology for natural wettability and high levels of comfort†2,3
  • UV blocker to help protect eyes from the transmission of harmful UV rays#
  • Live® is plastic neutral. CooperVision offsets plastic waste for every box of Live®  contact lenses sold and distributed.‡4

AquaGen® Technology

AquaGen® Technology attracts and binds moisture to the surface and throughout the material resulting in a naturally wettable lens and good overall comfort.3

Product Details

Material / H20 content
somofilcon A / 56%
UV blocker#
Yes
Replacement schedule
Daily Replacement
Oxygen transmissibility
86 Dk/t (at -3.00D)
Thickness
0.07mm (@ -3.00DS)
Revenue carton size
30, 90
Base curve
8.6mm
Diameter
14.0mm
Sphere power
-10.00 to -6.50DS (0.50D steps)
-6.00 to -0.50DS (0.25D steps)
+0.50 to +6.00DS (0.25D steps)
+6.50 to +8.00DS (0.50D steps)

Packaging images for illustration purposes only.
 

* During daily wear.
† At dispense.
# Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed.
‡ Plastic used in participating CooperVision soft contact lens products is determined by the weight of plastic in the blister, the lens, and the secondary package, including laminates, adhesives, and auxiliary inputs (e.g. ink). The determination does not include plastic used during the manufacturing process for both these products and their packaging.
 

References:
1. Brennan NA. Beyond Flux: Total Corneal Oxygen Consumption as an Index of Corneal Oxygenation During Contact Lens Wear. Optom Vis Sci. 2005;82(6):467-472.
2. CVI data on file, 2017. Randomised, controlled, subject-masked, bilateral, crossover clinical study.1-week DW with Live® and DACP. N=50 habitual soft CL wearers.
3. CVI data on file, 2024. CVI data on file, 2017. Bilateral, 1-week dispensing study with Live®, n=50.
4. CVI data on file, 2024.

For the device safety, warnings, precaution, and local regulatory information, please refer to the Instruction for use leaflet.

 

 

SA12738 / APP133845